chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient was vaccinated with a booster dose in left arm by pharmacy technician. Then received another COVID 19 Booster dose in the same arm 4 minutes later. Patient left and came back to the pharmacy 10 minutes later to inform the pharmacy team that she had mistakenly  received 2 booster doses. Patient didn't report any side effects and felt normal. Patient was informed to call pharmacy if any side effects or issues were to occur.
Fever, sweats, chills, elevated heart rate, leg pain (front of both legs), headaches, fatigue. Lasted over the course of 2 days.
uncontrolled weeping; thoughts of self harm; extreme startle response; Emotional liability; This is a spontaneous report from a contactable other Healthcare Professional reported for herself. A 44-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), second dose via an unspecified route of administration, administered in arm right on 11Feb2021 12:00 at age of 44-year-old (Lot Number: EU9809) at single dose for COVID-19 immunization. The patient was not pregnant at the time of vaccination. Medical history included PMDD (premenstrual dysphoric disorder) but controlled by chemical menopause over 3 months, known allergies to shellfish. Concomitant medications included naproxen and elagolix sodium (ORILISSA). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took first dose bnt162b2 (Lot number: EL8982) administered in arm left on 21Jan2021 at 11:45 (at age of 44-year-old) at single dose for COVID-19 immunization.  The patient experienced emotional liability, uncontrolled weeping, extreme startle response, thoughts of self harm on 12Feb2021 16:00. The events was reported as non-serious and did not result in emergency room visit or physician office visit. Patient received treatment  for the adverse events which included clonazepam. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the events was unknown.
Arm and necked had swelled - called pharmacist the evening PREVNAR was administered to discuss reaction. He advised her to call MD. She went to MD that Thurs. or Fri. He thought she may have had shot in rotator cuff and irritated it. He recommended physical therapy. Started therapy once a week then, increased to twice a week. Pt. said she had a bubble in arm that injection was given. She has been having bad sweating events daily. Neck pain radiates down to fingertips. No change in the pain and sometimes worse. The pain is every day.
experiencing headaches; Also short memory lapses; This is a spontaneous report from a contactable consumer. A 66-year-old female (same age at vaccination) non-pregnant patient received first dose of bnt162b2 (BNT162B2, Solution for injection, lot: EN6200) via unspecified route of administration on 22Feb2021 at 02:30 PM as single dose in arm right for COVID-19 immunization. Medical history reported was allergies to Sulfa. Concomitant medications reported was citalopram hydrobromide (CITALOPRAM HBR, tablet) as 20 mg and Lisinopril Tablet as 2.5mg. Patient did not receive any other vaccine in four weeks. Patient didnt have covid prior vaccination nor tested post vaccination. On 07Mar2021, patient was experiencing headaches daily since Sunday and also short memory lapses. No treatment was received by patient in response to the events. Outcome of the events was not recovered.  No follow-up attempts are possible. No further information is expected.
patient woke up and his hands were shaking, the left side of his face was numb, and tingling in his hands and feet.  At this moment the face numbness went away, the feet and hands are better.
Case was hospitalized for Covid after receiving the primary Covid vaccine series.  * Acute hypoxemic respiratory failure due to COVID-19 (HCC) Assessment & Plan Patient was on oxygen during his prior hospital stay but was weaned off.  Felt worse again with an elevating CRP.  Chest x-ray with ongoing pulmonary infiltrates.  Febrile with a leukocytosis in the ED.  Procalcitonin undetected, unlikely bacterial infection.  He completed 6 days of dexamethasone but given his elevating CRP and recurrent symptoms with hypoxia, elected to restart dexamethasone on admission.  Remdesivir not started as patient had completed course during prior admission..  Contact/droplet isolation ordered.  He reports wanting to be full code.  PT consulted. - continue dexamethasone (Day 5 at discharge). Will complete 7 day course - continued incentive spirometry throughout hospitalization
Heart palpitations leading to insomnia. Palpitations occur sometimes during the day, but get worse at night.
Swelling, redness, warmth, pain and fever ROCEPHIN, Prednisone.
A lump developed within the day. It was red & warm to the touch. I gave it 8 weeks, per what the Dr suggested. The lump hadn't gone down and was bruised still. I was told to give it longer. It has now been 8 days short of 4 months after the vaccine. The lump hasn't gone down any and is still tender to the touch.
very lethargic, nausea, severe migraines, cold sweats, severe body aches
patient reported intense COVID symptoms as well as nausea, dizziness, pressure in his head. Patient was diagnosed with COVID in January 2021.
Burning sensation in outer edge of left ear; This is a spontaneous report from a contactable other healthcare professional, the patient. A 44-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 30Mar2021 at 10:00 as a single dose for COVID-19 immunisation. Medical history was not reported. The patient was not allergic to any medications, food, or other products. Concomitant medication included naproxen (MANUFACTURER UNKNOWN). The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On an unknown date in Mar2021, the patient experienced burning sensation in outer edge of left ear. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care visit. The patient did not receive any treatment for the event. The clinical outcome of the event burning sensation in outer edge of left ear was not resolved at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
cough x 1wk, rash all over body, soap change 3 wk ago; tx w/DPh PRN;
Body aches,  fever, chills, fatigue, swelling at injection site.  Started with aches that night progressed to fever the next day. Resolved completely in about 36 hours.
Information has been received from a physician concerning a patient who was vaccinated with the haemophilus B conjugate vaccine (manufacturer unknown). Subsequently, the patient developed a high fever of 103-104 after last haemophilus B conjugate vaccine. The patient did not seek medical attention. No further information is available.
2 shots and still got shingles/ suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.     Additional Information: GSK receipt date: 2-June-2022 Reporter's comment:  This case was reported by a patient via interactive digital media. The patient had the expensive 2 shots and still got shingles. The patient stated that it was no joke, Be prepared and if you find a rash go to the doctor immediately. Additional Supportive Information: This case was considered as suspected vaccination failure since the details regarding time to onset and laboratory confirmation of shingles was not provided.
sore muscles/tightness around back and upper shoulders night of vaccination and continued for 2 days per patient
Sudden and total hearing loss in right ear, nausea, vomiting. Tinnitus Severe
Headache; Feverish; This case was reported by a consumer via call center representative and described the occurrence of headache in a 67-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 13th January 2021, the patient received the 2nd dose of Shingrix (intramuscular). On 13th January 2021, 12 hrs after receiving Shingrix, the patient experienced headache and fever. On an unknown date, the outcome of the headache and fever were not recovered/not resolved.   It was unknown if the reporter considered the headache and fever to be related to Shingrix.  Additional details were reported as follows: About 12 hours after receiving the Shingrix patient began to feel feverish and developed a headache. The symptoms were not resolved till the time of reporting. The reporter gives permission to contact his physician.  The patient asked how long the side effects should last.  The reporter consented to follow up.
This spontaneous report as received from a pharmacist via company representative refers to a female patient on unknown age. On an unknown date the patient was vaccinated with a dose of ZOSTAVAX (subcutaneously, dose was not reported, Lot # and expiration date were not provided). On the following day (date unspecified) the patient experienced diarrhoea and vomiting. The outcome of vomiting and diarrhoea was reported as recovered/resolved (date unspecified). The relatedness between the events and ZOSTAVAX was not reported. Additional information has been requested.
Temperature 101-103 approximately 24 hrs. post vaccination and loose stools - presented in clinic - no other symptoms.
mom states pt slept until 10PM p/vax;pt was given APAP once woke was irritable, spit up formula, would only take small amount of H2O & apple juice;cont to be irritable & not sleep for past 2 days;mom took pt to MD;pt had poor skin turgor
sore arm; Chills; Headache; swollen lymph nodes; Fever; Myalgia; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (sore arm), CHILLS (Chills), HEADACHE (Headache), LYMPHADENOPATHY (swollen lymph nodes) and PYREXIA (Fever) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 06-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm), CHILLS (Chills), HEADACHE (Headache), LYMPHADENOPATHY (swollen lymph nodes), PYREXIA (Fever) and MYALGIA (Myalgia). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (sore arm), CHILLS (Chills), HEADACHE (Headache), LYMPHADENOPATHY (swollen lymph nodes), PYREXIA (Fever) and MYALGIA (Myalgia) outcome was unknown.            N o relevant concomitant medications reported.  Action taken with mRNA-123 is not applicable.
Patient has been losing at least the 60% hair in the past 6 months.  She was diagnosed by biopsy with "telogenic efluvian"; Diagnosed by biopsy with telogenic efluvian, same in the past after a surgery, but not so intense like now; This spontaneous case was reported by a nurse and describes the occurrence of ALOPECIA (Patient has been losing at least the 60% hair in the past 6 months.  She was diagnosed by biopsy with "telogenic efluvian") and DIFFUSE ALOPECIA (Diagnosed by biopsy with telogenic efluvian, same in the past after a surgery, but not so intense like now) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048A21A and 037D21A) for COVID-19 vaccination.     The patient's past medical history included Telogen effluvium.   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ALOPECIA (Patient has been losing at least the 60% hair in the past 6 months.  She was diagnosed by biopsy with "telogenic efluvian") and DIFFUSE ALOPECIA (Diagnosed by biopsy with telogenic efluvian, same in the past after a surgery, but not so intense like now). At the time of the report, ALOPECIA (Patient has been losing at least the 60% hair in the past 6 months.  She was diagnosed by biopsy with "telogenic efluvian") and DIFFUSE ALOPECIA (Diagnosed by biopsy with telogenic efluvian, same in the past after a surgery, but not so intense like now) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Biopsy: telogen effluvium (abnormal) She was diagnosed by biopsy with telogen effluvium.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication provided.  No treatment medication provided.   Most recent FOLLOW-UP information incorporated above includes: On 20-Oct-2021: Reporter address and patient age updated
The day after the 2nd Moderna Vaccine, I began feeling dizzy.  It seems to be worse as the day wears on.
Tiny red itchy bumps all over palms of hands for about 16 hours. They were gone the next day.
severe myalgias starting at 18-20yrs after injection that resulted in her screaming in bed and taking old pain pills. myalgias have continued taking pt from no assistive devices to walker x 5 days. Maybe a bit better day 5. darkening of urine.
Little pain in my arm; Pain with movement; I may have been more tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Little pain in my arm), PAIN (Pain with movement) and FATIGUE (I may have been more tired) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A, 024M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Jan-2021, the patient experienced PAIN IN EXTREMITY (Little pain in my arm), PAIN (Pain with movement) and FATIGUE (I may have been more tired). At the time of the report, PAIN IN EXTREMITY (Little pain in my arm), PAIN (Pain with movement) and FATIGUE (I may have been more tired) outcome was unknown.            No concomitant medication was reported.  Treatment medication was not provided by the reporter.  Action taken with mRNA-1273 in response to the event was not applicable.
This spontaneous report as received from a 82 year old female patient, refers to herself. The patient had no pertinent medical history and no drug reactions or allergies. On an unknown date in August 2012 the patient was vaccinated with the dose of ZOSTAVAX 1 time vaccine (lot number was not reported), administered by subcutaneous route. Concomitant therapies included calcium (unspecified), used daily. On an unknown date in April 2013 the patient was diagnosed with shingles after getting the ZOSTAVAX vaccine. The patient stated that it was on the right side of her face, and went to her neck, and the back of her head. The patient sought medical attention. Lab diagnostics studies were not performed. The patient was treated for the event with an unspecified therapy. The patient stated that the event improved on the therapy (on an unknown date). Relatedness between event and ZOSTAVAX was not reported. Additional information has been requested.
her friend who is a nurse said she is still feeling sore; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received bnt162b2 (PFIZER COVID19 VACCINE,solution for injection, Batch/Lot number was unknown,exipery date was not reported),via an unspecified route of administration,adminstered in left arm on an unspecified date as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. The patient medical history and The patient's concomitant medications were not reported. The patient experienced her friend who is a nurse said she is still feeling sore (pain) on an unspecified date. The clinical outcome of the event was unknown.  Information on the lot/batch number has been requested.
Patient is a 16 y.o. previously healthy male transferred from different Hospital for chest pain and elevated troponin. He had received his 2nd dose Covid vaccine (Pfizer) on Saturday 5/22, then had a fever to 103 on Sunday and then 101 on Monday measured by laser thermometer to forehead, associated with chills. Mother gave him Advil for fever. States he was awakened from sleep on Tuesday 5/25 at ~4am by a sharp chest pain. He describes a non-radiating, aching pain with some sense of pressure in the LUSB that initially lasted 2 hours. Once he arrived to Hospital it went away completely, but then returned several times after lasting about 30-60min each. Denies pleuritic pain, positional pain, dyspnea, or exertional pain. Tried Ibuprofen  which he feels helped, but then the pain returned 30min later. Also endorsed headache and fatigue.    At Hospital he had elevated troponin concerning for mild myocarditis.  EKG had diffuse ST elevation suggestive of possible pericarditis.
Healthy 10 month old has received 3 doses of Prevnar vaccine per routine schedule. Develped fever for 24 hours and URI symptoms for a couple of weeks. Blood culture positive for strep pneumonaie.
3 am woke up with stomach upset cramping, nausea, chills, took Tylenol; no appetite not eating anything
Red rash on face that progressed to ears, hands, elbows, and knees. Nightly low grade temperatures, arthritis and proximal muscle weakness. Diagnosed with dermatomyositis on 12/9/2014.
[Moderna Covid Vaccine] use for COVID-19 under Emergency Use Authorization (EUA): covid pneumonia in a patient with two moderna covid shots
they did ultrasound and found a blood clot in her right leg behind the knee; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DEEP VEIN THROMBOSIS (they did ultrasound and found a blood clot in her right leg behind the knee) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension. Concomitant products included LIRAGLUTIDE (VICTOZA) and INSULIN GLARGINE (TOUJEO) for an unknown indication.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 12-Apr-2021, the patient experienced DEEP VEIN THROMBOSIS (they did ultrasound and found a blood clot in her right leg behind the knee) (seriousness criterion medically significant). At the time of the report, DEEP VEIN THROMBOSIS (they did ultrasound and found a blood clot in her right leg behind the knee) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Apr-2021, Ultrasound scan: found a blood clot in her right leg behind the kne (abnormal) found a blood clot in her right leg behind the knee.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included xarelto 15mg.  Concomitant medication included BP medicine.   Her right leg started swelling and turned red a week ago(10Apr2021). She went to the doctor on 12Apr2021 and they did ultrasound and found a blood clot in her right leg behind the knee (12Apr2021). She is scheduled to get 2nd dose on 22Apr2021. She never had blood clot before so wanted to report it.  Company comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested
Bursitis of right knee Pain in right calf travelled to behind knee then to back of thigh
Patient described pain at injection site at time of injection, stated she experienced feelings of numbness and difficulty with grip/making a fist within minutes to hours afterwards. Arm pain got progressively worse over the course of the day. Patient took one dose of ketorolac that she had on hand to help with pain/swelling. Patient was seeking medical attention at an urgent care for pain the next morning, also stated she was experiencing difficulty focusing her thoughts, tingling sensation on her scalp/back of her head. At the time of this reporting, no information regarding the result of the urgent care visit.
Patient received HEP A #1 and Varivax #2 in office.  Complained of arm soreness.  Driving home in car with MOC passed out.  Paramedics were called and patient taken to hospital.
Four days after initial vaccine she developed chest tightness and palpitations which occurred intermittently and then gradually faded. Again four days after the second shot she developed palpitations. This time she was undergoing heart monitoring which revealed several episodes of symptomatic SVT. These have gradually reduced over time but not completely resolved. She had no previous cardiac history.
Muscle pain, stiffness and weakness in lower extremities, foot tremors, shuffling gait, loss of appetite, behavior change, lethargy and low grade fever (AVG 100 deg) - onset approximately 6:30 PM following vaccinations lasting 4.5 days.  Severe chills, full body engaged, clenched teeth, difficulty waking - non-responsive to being moved, loud noises at 11:30 PM evening of vaccinations.  Doctor visit on 25 July for muscle pain, muscle tremors refusal/inability to walk, required strong encouragement to walk - walked with shuffling gait. 100 deg temperature decreased to normal 98.7 by morning of 27 July 2008.
Covid-19 Positive; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Covid-19 Positive) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Covid-19 Positive). At the time of the report, COVID-19 (Covid-19 Positive) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomitant medications are not provided. Treatment information does not provided.